| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |